Clinical Trial Update: V+PSF-M for Tobacco Cessation in HIV Care in India [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating V+PSF-M for tobacco cessation in people living with HIV in India is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• V+PSF-M

Snippet

Sponsor: University of Colorado, Denver | Conditions: Human Immunodeficiency Virus, Smoking Cessation | Phase 3 | Status: RECRUITING